Quarter Financials
Neurocrine Biosciences, Inc. (NBIX)
$91.22
-0.96 (-1.04%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | 89 | 69 | -17 | 14 | -7 | 23 | 42 | 32 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | - | -496 | -564 | -547 | -636 | -629 | -651 | -693 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -0 | - | -9 | -8 | -9 | -6 | -4 | -5 |
|---|
| Net PPE | 146 | 151 | 159 | 159 | 156 | 149 | 150 | 142 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | -94 | -289 | -280 | -141 | -201 | -61 | -134 | -226 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|